Chronic Kidney Disease: An Overview

Authors

  • Prashant Tiwari Department of Pharmacology, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan (deemed to be University), Bhubaneswar, Odisha, India
  • Deepak Dash Department of Pharmaceutical Chemistry and Analysis, Royal College of Pharmacy, Raipur, Chhattisgarh, India
  • Priyadarshini Biswal Department of Pharmacology, School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan (deemed to be University), Bhubaneswar, Odisha, India

DOI:

https://doi.org/10.37591/rrjom.v8i1.281

Abstract

The key purpose of this review article is to throw light on chronic kidney disease (CKD). Each day people are diagonised with CKD making the need of proper awareness regarding CKD, one of the top public health priorities. Taking this into consideration, the review article outlines some new insight on identification of CKD, classifying it into several stages based on glomerular filtration rate (GFR)/chronic renal failure (CRF) value to be calculated using certain techniques, probable pathophysiology and etiology of CKD along with the therapeutic treatment available to reduce its progression. It also states the effect of CKD towards development of symptomatic anaemia and the best possible preventive measures to treat it. It summons the need of hour for understanding CKD and its effects.

 

Keywords: Chronic kidney disease, angiotensin converting enzyme inhibitors

 

Cite this Article

Prashant Tiwari, Deepak Dash, Priyadarshini Biswal. Chronic Kidney Disease (CKD): An Overview. Research & Reviews: Journal of Medicine. 2018; 8(1): 6–9p.

Downloads

Published

2018-05-18

Issue

Vol. 8 No. 1 (2018)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.